In re Namenda Direct Purchaser Antitrust Litigation – Antitrust Class Action Settlement

Berger Montague served as co-lead counsel and obtained a $750 million settlement on behalf of a class of direct purchasers of branded and/or generic Namenda IR and/or branded Namenda XR, from Forest or its successors in interest, Actavis and Allergan, and/or from any generic manufacturer at any time during the period from June 2012 to September 2015. Led by David F. Sorensen of Berger Montague, the case was litigated in the United States District Court for the Southern District of New York and captioned In re Namenda Direct Purchaser Antitrust Litigation, No. 15-cv-7488 (S.D.N.Y.). This is the largest single-defendant settlement in U.S. history for a case alleging delayed generic competition.

If you or your company has been harmed by anticompetitive conduct or any conduct that you believe violates the antitrust laws, please contact Berger Montague.

About Berger Montague

Berger Montague is a national law firm focusing on complex civil litigation in federal and state courts throughout the United States. For over half a century, Berger Montague has played lead roles in consequential, precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago, Minneapolis, San Diego, San Francisco, Toronto, and Washington, D.C.